SLLK, Control Peptide for TSP1 Inhibitor 5mg

General information
 

Name:
SLLK, Control Peptide for TSP1 Inhibitor 5mg
Size:
5mg
Catalog no:
CS-7050-5mg
Price:
438 EUR
 

Additional extra details
 

  • Alternative_Names

    NA

    CAS

    464924-27-4

    Purity

    >98%

  • MWt

    459.58

    Formula

    C21H41N5O6

    Solubility

    H2O

  • Clinical_Information

    No Development Reported

    Pathway

    Others

    Target

    Others

  • Tissue

    control

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.